sonidegib
Sign in to saveAlso known as LDE225, erismodegib (deleted INN), LDE-225, NVP-LDE225, Odomzo®, NVP-LDE 225, LDE 225, Erismodegib
Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.
Chemical data
- Formula
- C26H26F3N3O3
- Molecular weight
- 485.5 g/mol
- IUPAC name
- N-[6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-3-pyridinyl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2015
- Admin. routes
- oral
- Indications
- breast neoplasm, neoplasm, liver disease, medulloblastoma
via ChEMBL · EBI
~2 min read
Article
5 sectionsContents
- Approvals and indications
- Pharmacology
- Development
- References
- External links
Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.
Sonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism).